Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7150
+0.0050 (0.29%)
NASDAQ · Last Trade: Jan 12th, 8:00 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors